Corvite 150none

Multivitamins (MVM)

Brand: Vertical Pharmaceuticals

Tablet or PillMulti-Vitamin and Mineral (MVM)On Market
Click to view full label

Net Contents

30 Tablet(s)

Serving Size

1 Tablet(s)

Servings Per Container

30

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

3 68025-052-30 6

Product Version

Rev. 08/13 Product Code: 68025-052-30

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

9Active Ingredients

9 distinct active ingredients are disclosed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

9% Daily Value Coverage

9 ingredients report a %DV; 6 meet or exceed 100% DV.

3Dietary Attributes

Label states: Vegan, Vegetarian, Gluten-Free.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Allergen Guide

Free From

  • Gluten

Allergen flags are parsed automatically from the official label's claims and statements. Always verify against the physical product label before use, especially if you have a severe allergy.

Supplement Facts

Serving Size: 1 Tablet(s) · 1 per day

IngredientAmount Per Serving% Daily Value
Vitamin C(Calcium Ascorbate)120 mg200%
Calcium Threonate5 mg0.5%
Vitamin B6(Pyridoxine Hydrochloride)10 mg500%
Vitamin B7(Biotin)100 mcg33%
Vitamin B12(Cyanocobalamin)20 mcg333%
Folate1 mg250%
Folic Acid700 mcg
Quatrefolic((6S)-5-Methyltetrahydrofolic Acid Glucosamine Salt)300 mcg
Iron(Ferronyl Carbonyl Iron, Powder)150 mg833%
Magnesium(Magnesium Oxide)10 mg3%
Zinc(Zinc Citrate)25 mg167%

Not Present

Other Ingredients

Microcrystalline CelluloseStarch, PregelatinizedDicalcium PhosphateHydroxypropylmethylcellulosePolyvinyl alcoholFD&C Red #40 LakePolyethylene GlycolTalcTitanium DioxideCroscarmellose SodiumStearic AcidMagnesium Stearate

Target Groups

VeganVegetarianAdult (18 - 50 Years)Gluten FreeSugar Free

Label Claims

NutrientAll OtherStructure/Function

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

Dosage & Administration Usual adult dose is 1 tablet daily, or as directed by a physician.

Warnings & Precautions

Precautions re: Children

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions re: All Other

Contraindications: Corvite 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy. Warnings: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. Precautions General: Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with Corvite 150. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia

Precautions re: Children

Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

Precautions re: All Other

Geriatric Use: Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious. Adverse Reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.

Precautions re: Allergies

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Precautions re: All Other

Overdosage: The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Precautions re: Children

Keep out of the reach of children.

Precautions re: All Other

Call your doctor about side effects.

Storage

Storage

Storage Store at controlled room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F) [see USP]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined by the USP using a child-resistant closure.

Formulation

Formula re: Contains

Now with Quatrefolic

Formula re: Contains

Iron Supplementation

Formulation re: Does NOT Contain

Sugar, lactose & gluten free

Formulation re: Vegetarian/Vegan

Vegan safe

Formula re: Contains

Clinical Pharmacology: Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of vitamin B12 from the gastrointestinal tract.

Formulation re: Other

Indications and Usage: Corvite 150 is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.

Other Label Statements

General Statements: All Other Content

68025-052-30 Rx only

Brand IP Statement(s) re: (c), (TM), (SM)

Patent pending

Brand IP Statement(s) re: (c), (TM), (SM)

Quatrefolic is a registered trademark of Gnosis, SpA. -U.S. Patent No. 7,947,662.

General Statements: All Other Content

Description: Corvite 150 are red, oval bisected tablets embossed "VP052." How Supplied: Corvite 150 tablets are supplied in bottles of 30 units.

General Statements: All Other Content

Lift here for full product information

Manufacturer & Distributor

Distributor

Vertical Pharmaceuticals, Inc.

Sayreville, NJ, 08872

Other

1-877-958-3784

Market Reference

$43.20· 1 listing
  • Corvita 150, null TABLET

    Amazon.com
    $43.20Lowest

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

  • Holland & Barrett - Stratford Upon Avon

    4.6 (25)

    Vitamin & Supplements Shop

    31 Bridge St, Stratford-upon-Avon CV37 6AD

  • Revital

    4.1 (14)

    Vitamin & Supplements Shop

    16 High St, Stratford-upon-Avon CV37 6AU

  • Holland & Barrett - Leamington Spa

    4.6 (39)

    Vitamin & Supplements Shop

    41 Parade, Leamington Spa CV32 4BL

Research & Studies

  • BAERT Kim CORLUY Michiel DE KOONING Nick DIAKANASTASI Elli VANHERK Thomas

    P Matthyssens, J Vanderstraeten - academia.edu

    Writing an extensive paper as such, together with five fellow students, has at least been an honour for me during this entire postgraduate academic year. Hence, some words of gratitude …

  • Incumbents adaptation to uncertain competence-destroying changes: Real options perspective

    M Ahsan - 2006 - search.proquest.com

    In this dissertation I examine the manner in which incumbent firms adapt to competence destroying technological change when the scientific value and social acceptance of those …

    2006
  • Design of a polysaccharide derived tissue engineered vascular graft

    IS Robu - 2010 - search.proquest.com

    According to the World Heart Organization, cardiovascular diseases claim 17.1 million lives each year, from which congenital heart defects account for 26%. As the most frequent …

    2010
  • Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair

    I Abraha, ML Luchetta, R De Florio… - The Cochrane …, 2017 - pmc.ncbi.nlm.nih.gov

    Background People with abdominal aortic aneurysm who receive endovascular aneurysm repair (EVAR) need lifetime surveillance to detect potential endoleaks. Endoleak is defined as …

    201783 citations
  • Labor, Capital, and Machine: Toward a Labor Process Theory for HCI

    Y Qin, EJ Cheon - Proceedings of the 2026 CHI Conference on Human …, 2026 - dl.acm.org

    The HCI community has called for renewed attention to labor issues and the political economy of computing. Yet much work remains in engaging with labor theory to better understand …

    20261 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2021-12-18. DSLD Label ID: 264174. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.